DYNLRB1 and neoplasm: Although the target lesion remained stable at the first follow-up, bITH score increased sharply when loss-of-function mutations of many tumor suppressor genes occurred, resulting a 49-day lead-time on detection of progression compared with the radiological assessment (Fig. 5B).